Insulet Corp
NASDAQ:PODD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Insulet Corp
NASDAQ:PODD
|
US |
|
Reading International Inc
NASDAQ:RDI
|
US |
|
M
|
Mitsib Leasing PCL
SET:MITSIB
|
TH |
|
Eterna Therapeutics Inc
NASDAQ:ERNA
|
US |
|
Superdry PLC
LSE:SDRY
|
UK |
|
C
|
Central Puerto SA
BCBA:CEPU
|
AR |
|
HOOKIPA Pharma Inc
NASDAQ:HOOK
|
US |
|
M
|
Mitsubishi Logistics Corp
F:MIB
|
JP |
|
Mips AB
STO:MIPS
|
SE |
|
Darkpulse Inc
OTC:DPLS
|
US |
|
ACADIA Pharmaceuticals Inc
NASDAQ:ACAD
|
US |
Wall Street
Price Targets
PODD Price Targets Summary
Insulet Corp
According to Wall Street analysts, the average 1-year price target for
PODD
is 363.7 USD
with a low forecast of 288.86 USD and a high forecast of 456.75 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is PODD's stock price target?
Price Target
363.7
USD
According to Wall Street analysts, the average 1-year price target for
PODD
is 363.7 USD
with a low forecast of 288.86 USD and a high forecast of 456.75 USD.
What is Insulet Corp's Revenue forecast?
Projected CAGR
20%
For the last 14 years the
compound annual growth rate for
Insulet Corp's revenue is
23%.
The projected
CAGR
for the next 3 years is
20%.
What is Insulet Corp's Operating Income forecast?
Projected CAGR
27%
The
compound annual growth rate
of Insulet Corp's operating income for the next 3 years is
27%.
What is Insulet Corp's Net Income forecast?
Projected CAGR
44%
The
compound annual growth rate
of Insulet Corp's net income for the next 3 years is
44%.
